Log in to save to my catalogue

Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning amon...

Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning amon...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c1845664d8ab4087b5e3ff2e1f6eb4bc

Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study

About this item

Full title

Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study

Publisher

England: BioMed Central Ltd

Journal title

Breast cancer research : BCR, 2025-02, Vol.27 (1), p.25-7, Article 25

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Apolipoprotein Ɛ4 genotype (APOE4) has been associated with cancer-related cognitive impairment, but its interaction with treatments remains unclear. This longitudinal study aims to evaluate the association between APOE4 and cognitive impairment in women with breast cancer (BC) undergoing chemotherapy (CT) or endocrine therapy (ET).
Patients wit...

Alternative Titles

Full title

Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c1845664d8ab4087b5e3ff2e1f6eb4bc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c1845664d8ab4087b5e3ff2e1f6eb4bc

Other Identifiers

ISSN

1465-542X,1465-5411

E-ISSN

1465-542X

DOI

10.1186/s13058-025-01974-2

How to access this item